Henry Schein (WBO:HSIC) Research & Development: €0 Mil (TTM As of Mar. 2026)


WBO:HSIC Henry Schein Inc WBO:HSIC
73 GF Score
Price €74.00
GF Value €73.91
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Henry Schein Research & Development?

Henry Schein WBO:HSIC +1.37% 73 Research & Development is €0 Mil as of Mar. 2026. GuruFocus rates WBO:HSIC with a GF Score™ of 73/100 and a GF Value™ of €73.91 (Fairly Valued). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Henry Schein's Research & Development for the three months ended in Mar. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0 Mil.

Henry Schein  (WBO:HSIC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Henry Schein Research & Development Related Terms

Henry Schein Research & Development Historical Data

* Premium members only.

The historical data trend for Henry Schein's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Henry Schein Research & Development Chart

Henry Schein Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Henry Schein Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WBO:HSIC
73GF Score
Henry Schein Inc WBO:HSIC
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Henry Schein Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Henry Schein (WBO:HSIC) has a Research & Development of €0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Henry Schein and its competitors.
Is Henry Schein's Research & Development too high?
Henry Schein's current Research & Development is €0 Mil. Overall, Henry Schein has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Henry Schein's Research & Development compare to AHG and ACH?
Henry Schein's Research & Development of €0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Distribution company?
A good Research & Development depends on the Medical Distribution industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Henry Schein and its competitors. Henry Schein's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henry Schein stock overvalued right now?
Based on GuruFocus' analysis, Henry Schein (WBO:HSIC) is currently considered Fairly Valued. The stock's GF Value™ is €73.91, compared to a current price of €74.00 — trading 0.1% above its estimated fair value. The current Research & Development is €0 Mil. Henry Schein's overall GF Score™ is 73/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Henry Schein (WBO:HSIC), the current Research & Development is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Henry Schein (WBO:HSIC) Overvalued in 2026?

Based on GuruFocus' analysis, Henry Schein stock appears to be overvalued. The current stock price of €74.00 is trading 0.1% above its estimated GF Value™ of €73.91. GuruFocus considers Henry Schein to be Fairly Valued.

Key valuation signals for WBO:HSIC:

  • Research & Development: €0 Mil
  • GF Value™: €73.91 vs. price of €74.00 (0.1% above fair value)
  • GF Score™: 73/100 with 8 warning signs

No single metric tells the full story. See the WBO:HSIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Henry Schein Business Description

Address 135 Duryea Road, Melville, NY, USA, 11747
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
73GF Score

Get the complete analysis for WBO:HSIC

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€74.00
Price
€73.91
GF Value